DarioHealth Corp. (DRIO)

Market Cap	53.21M +47.8%
Revenue (ttm)	21.00M -22.7%
Net Income	-7.00M
EPS	-0.95
Shares Out	9.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,522
Open	6.02
Previous Close	6.08
Day's Range	5.43 - 6.05
52-Week Range	5.43 - 16.55
Beta	1.18
Analysts	Strong Buy
Price Target	13.60 (+150.46%)
Est. Earnings	Nov 12, 2026

About DRIO

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the sympt...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 165
• Stock Exchange: Nasdaq
• Ticker Symbol: DRIO
• Website: https://www.dariohealth.com

Financial Performance

In 2025, DarioHealth's revenue was $22.36 million, a decrease of -17.31% compared to the previous year's $27.04 million. Losses were -$40.31 million, 34.0% more than in 2024.

Analyst Summary

According to 5 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price target is $13.6, which is an increase of 150.46% from the latest price.

Price Target

$13.6

(150.46% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 8, 2026

Data Sources Report a data error